Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Northern Trust Corp

Northern Trust Corp grew its stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 7.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 245,110 shares of the company's stock after buying an additional 16,421 shares during the period. Northern Trust Corp owned 0.61% of Phibro Animal Health worth $5,147,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the stock. Aquatic Capital Management LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth about $69,000. Nebula Research & Development LLC purchased a new position in Phibro Animal Health during the 4th quarter worth approximately $210,000. Price T Rowe Associates Inc. MD lifted its stake in Phibro Animal Health by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,668 shares of the company's stock valued at $372,000 after buying an additional 1,565 shares during the last quarter. Hsbc Holdings PLC lifted its stake in Phibro Animal Health by 53.5% in the fourth quarter. Hsbc Holdings PLC now owns 17,709 shares of the company's stock valued at $372,000 after buying an additional 6,169 shares during the last quarter. Finally, State of Tennessee Department of Treasury boosted its holdings in shares of Phibro Animal Health by 19.3% in the fourth quarter. State of Tennessee Department of Treasury now owns 19,523 shares of the company's stock valued at $410,000 after acquiring an additional 3,153 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the stock. Morgan Stanley upped their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. Barclays increased their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Finally, Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and a consensus target price of $20.00.

Phibro Animal Health Price Performance

Phibro Animal Health stock traded up $0.22 during midday trading on Monday, reaching $23.24. The company's stock had a trading volume of 135,439 shares, compared to its average volume of 199,023. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The firm has a market capitalization of $942.01 million, a PE ratio of 48.42, a P/E/G ratio of 0.45 and a beta of 0.62. The stock's 50 day simple moving average is $20.31 and its 200 day simple moving average is $21.87.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. On average, equities research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.07%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is 61.54%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.